André P. Dieskau

Discovering molecules that matter as Peptides and Specialties Lead @ Pharma R&D, VP

Germany

About

Experience

  • Bayer (12 yrs 6 mos)
    • Vice President, Peptides & Specialties Lead @ Drug Discovery Sciences
      Sep 2024 - Present · 1 yr 11 mos

    • Sen. Director, Head of Process Chemistry Technologies and Solid State Sciences
      Feb 2022 - Sep 2024 · 2 yrs 8 mos

      ▪ Leading a team of 50 highly skilled scientists and technology experts supporting Pharma development pipeline (SMOLs, New Modalities) ▪ Key areas: reaction optimization, analytics, chromatography, process optimization including online spectroscopy (PAT) & chiral resolutions, material science, PhysChem ▪ Responsible for digital transformation in Chemical API Development

    • Head of Process Chemistry Technologies
      Oct 2020 - Jan 2022 · 1 yr 4 mos

      ▪ Leading a team of 25 highly skilled scientists and technology experts supporting Pharma development pipeline (SMOLs, New Modalities) ▪ Responsible for digital transformation in Chemical Development

  • Postdoctoral Associate - Professor Larry E. Overman at University of California Irvine
    Jul 2012 - Dec 2013 · 1 yr 6 mos

    ▪ Total synthesis of alkaloids and terpenes ▪ Application of photredox-catalyzed fragment couplings in total synthesis

  • PhD student - Professor Bernd Plietker at University of Stuttgart
    Apr 2008 - May 2012 · 4 yrs 2 mos

  • Research Associate - Professor Barry M. Trost at Stanford University
    Sep 2010 - Dec 2010 · 4 mos

  • Internship Medicinal Chemistry at Eli Lilly and Company
    Aug 2006 - Oct 2006 · 3 mos